Lv1
40 积分 2022-12-05 加入
A patent review of small molecular inhibitors targeting EGFR exon 20 insertion (Ex20ins) (2019-present)
4天前
已完结
Challenges, opportunities and therapeutic potential of JAK inhibitors and their derived PROTACs (2022 – 2023)
4天前
已完结
Selective and Potent Molecular Glue Degraders for NIMA‐related Kinase 7
4天前
已完结
Discovery of Novel SIK2/3 Inhibitors for the Potential Treatment of MEF2C+ Acute Myeloid Leukemia (AML)
8天前
已完结
Discovery of a Potent SARM1 Base-Exchange Inhibitor with In Vivo Efficacy
8天前
已完结
PI4KA and PIKfyve: Essential phosphoinositide signaling enzymes involved in myriad human diseases
12天前
已完结
Discovery and Identification of Small Molecules as Methuosis Inducers with in Vivo Antitumor Activities
15天前
已完结
UNC9426, a Potent and Orally Bioavailable TYRO3-Specific Inhibitor
16天前
已完结
Discovery of Novel, Potent, Orally Bioavailable and Efficacious, Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors for Hematopoietic Stem Cell Mobilization
19天前
已完结
Structure-Based Development of 3,4-Fused Tricyclic Benzofuran Derivatives as Polyketide Synthase 13 Inhibitors with Negligible hERG Inhibition
19天前
已完结
皖公网安备34019202002308
